Meeder Asset Management »

Kymera Therapeutics shares owned by Meeder Asset Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Meeder Asset Management from 13F filings

Historical chart of Meeder Asset Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Meeder Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.0k 72 27.38

More positions owned by Meeder Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Jpmorgan Usd Emg (EMB)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Costco Wholesale Corporation (COST)
Bank of New York Mellon Corporation (BK)
Amazon (AMZN)

View all positions for Meeder Asset Management

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
FMR
BVF
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Driehaus Capital Management
Ubs Global Asset Management Americas

View all funds holding Kymera Therapeutics